XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Other Assets
 6 Months Ended
Jun. 30, 2023
Other Assets  
Other assets
5.Other assets

 

   As of
June 30,
2023
(unaudited)		   As of
December 31,
2022		 
   (in €) 
Non-current other assets        
Prepaid expenses   283,784    308,066 
Total   283,784    308,066 
Current other assets          
Prepayments on research & development projects   4,757,771    9,776,505 
Prepaid expense   1,146,674    1,841,935 
Others   501,422    2,552,071 
Total   6,405,867    14,170,511 
Total other assets   6,689,651    14,478,577 

 

As of June 30, 2023, prepayments on research & development projects amounted to €4.8 million compared to €9.8 million as of December 31, 2022, and consist of prepayments on clinical and R&D material production contracts. The decrease in prepayments results from manufacturing development activities, which were partly completed in the six months ended June 30, 2023.

 

Prepaid expenses mainly consist of prepaid insurance expense.

 

The reduction of the amounts in the category “others” primarily relate to credit notes issued to the Company by CROs, which were still outstanding as of December 31, 2022 and were paid in 2023.